Company Profile

Vital Art And Science Inc
Profile last edited on: 1/15/14      CAGE: 4GEF0      UEI:

Business Identifier: smart phone-based home monitor products capable of diagnosing and monitoring age-related macular degeneration and diabetic retinopathy
Year Founded
2006
First Award
2009
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2725 North Spring Drive
Richardson, TX 75082
   (214) 929-2931
   info@myvisiontrack.com
   www.myvisiontrack.com
Location: Single
Congr. District: 03
County: Collin

Public Profile

Vital Art and Science Incorporated (VAS) is an ophthalmic medical device company which has developed an easy-to-use and accurate home diagnostic system that enables patients with a retinal disease to quickly and efficiently monitor their own vision function at home. myVisionTrack™ is an accurate, portable, and user-friendly system that enable patients with retinal diseases to quickly and efficiently monitor their own vision function at home. By using proprietary VAS software and a shape discrimination test implemented on a handheld electronic platform, myVisionTrack allows patients with degenerative eye disease such as diabetic retinopathy (DR) and Age Related Macular Degeneration (AMD) to quickly and accurately test their own visual function at home. In the past decade, new therapies have been developed for these degenerative eye diseases, but timely treatment is critical to their effectiveness. Unfortunately most patients are unable to self-detect the renewed disease activity with the paper eye charts (Amsler Grid) which are today’s standard. There is a very large need for an easy, quick and accurate test which patients can use to monitor their own disease progression. Patients can self-monitor their condition at home. Results of the test are stored, automatically compared with prior test results. In the event that a significant change is detected, the physician would be notified to review the data to determine if the patient needs to come in sooner for a check-up. With myVisionTrack, patients can now monitor their vision function in between regular visits to eye-care professional to help insure they obtain timely care and treatments. myVisionTrak TM is now FDA approved. Available on prescription, product expected in 4th quarter 201

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 2 NIH $1,263,594
Project Title: This Sbir Project Seeks To Develop A Low-Cost Home Vision Self-Test System Which

Key People / Management

  Michael B Bartlett -- President

  Thomas G Capetan -- VP Business Development and Strategy

  Yu-Guang He -- Chief Medical Officer

  William Krenik

  Yi-Zhong Wang -- Chief Science Officer

  Kang Zhang